UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.75 +0.27 (+0.34%) GOLD FUTURES
2,322.40 -8.80 (-0.38%) DOW
38,893.77 +41.50 (+0.11%) Bitcoin GBP
50,727.86 +243.60 (+0.48%)
PRTA May 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:42AM EDT. Market open.
| Previous close | 0.7500 |
| Open | 0.5500 |
| Bid | 0.5500 |
| Ask | 0.8000 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.5000 - 0.7100 |
| Contract range | N/A |
| Volume | |
| Open interest | 213 |
Business WireProthena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
© 2024 Yahoo. All rights reserved.